SEARCH

SEARCH BY CITATION

References

  • 1
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC: American Psychiatric, 2000.
  • 2
    National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults. 2008. Available at http://www.nice.org.uk/CG72 (last accessed 7 May 2013).
  • 3
    Fayyad J, De Graaf R, Kessler RC, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, Lépine JP, Ormel J, Posada-Villa J, Zaslavsky AM, Jin R. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007; 190: 402409.
  • 4
    Biederman J, Mick E, Surman C Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006; 59: 829835.
  • 5
    Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, Mick E, Aleardi M, Herzig K, Faraone S. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 456463.
  • 6
    Faraj BA, Israili ZH, Perel JM, Jenkins ML, Holtzman SG, Cucinell SA, Dayton PG. Metabolism and disposition of methylphenidate-C: studies in man and animals. J Pharmacol Exp Ther 1974; 191: 535547.
  • 7
    Markowitz JS, Straughn AB. Advances in the pharmacotherapy of ADHD: methylphenidate. Pharmacotherapy 2003; 23: 12811299.
  • 8
    Wargin W, Patrick K, Kilts C, Gualtieri CT, Ellington K, Mueller RA, Kraemer G, Breese GR. Pharmacokinetics of methylphenidate in man, rat and monkey. J Pharmacol Exp Ther 1983; 226: 382386.
  • 9
    Bartlett MF, Egger HP. Disposition and metabolism of methylphenidate in dog and man. Fed Proc 1972; 31: 537.
  • 10
    Redalieu E, Bartlett MF, Waldes LM, Darrow WR, Egger H, Wagner WE. A study of methylphenidate in man with respect to its major metabolite. Drug Metab Dispos 1982; 10: 708709.
  • 11
    Shah NS, Yates JD. Placental transfer and tissue distribution of dextro-amphetamine in the mouse. Arch Int Pharmacodyn Ther 1978; 233: 200208.
  • 12
    Burchfield DJ, Lucas VW, Abrams RM, Miller RL, DeVane CL. Disposition and pharmacodynamics of methamphetamine in pregnant sheep. JAMA 1991; 265: 19681973.
  • 13
    Taddio A, Ito S. Drugs and Breastfeeding, In: Koren G , Ed. Maternal –Fetal Toxicology, A Clinician's Guide, 3rd edn. New York: Dekker M, Inc, 2001; 177233.
  • 14
    Beckman DA, Schneider M, Youreneff M, Tse FL. Developmental toxicity assessment of d,l-methylphenidate and d-methylphenidate in rats and rabbits. Birth Defects Res B Dev Reprod Toxicol 2008; 83: 489501.
  • 15
    Cohen LS. Pharmacologic treatment of depression in women: PMS, pregnancy, and the postpartum period. Depress Anxiety 1998; 8: 1826.
  • 16
    Hackett LP, Ilett KF, Kristensen JH, Judith H, Kohan R, Hale TW. Infant dose and safety of breastfeeding for dexamphetamine and methylphenidate in mothers with attention deficit hyperactivity disorder. Ther Drug Monit 2005; 27: 220221.
  • 17
    Phillips B, Ball C, Sackett D Badenoch D, Straus S, Haynes B, Dawes M. Oxford Centre for Evidence-Based Medicine. Levels of Evidence. Oxford: Centre for Evidence-Based Medicine, 2009. Available at http://www.cebm.net/?o=1025 (last accessed 7 May 2013).
  • 18
    Debooy VD, Seshia MM, Tenenbein M, Casiro OG. Intravenous pentazocine and methylphenidate abuse during pregnancy. Maternal lifestyle and infant outcome. Am J Dis Child 1993; 147: 10621065.
  • 19
    Kopelman AE, McCullar FW, Heggeness L. Limb malformations following maternal use of haloperidol. JAMA 1975; 231: 6264.
  • 20
    Lundquest DE, Young WK, Edland JF. Maternal death associated with intravenous methylphenidate (Ritalin) and pentazocine (Talwin) abuse. J Forensic Sci 1987; 32: 798801.
  • 21
    Spigset O, Brede WR, Zahlsen K. Excretion of methylphenidate in breast milk. Am J Psychiatry 2007; 164: 348.
  • 22
    Adams J, Vorhees CV, Middaugh LD. Developmental neurotoxicity of anticonvulsants: human and animal evidence on phenytoin. Neurotoxicol Teratol 1990; 12: 203214.
  • 23
    Brand SR, Brennan PA. Impact of antenatal and postpartum maternal mental illness: how are the children? Clin Obstet Gynecol 2009; 52: 441455.